Status:
COMPLETED
Neurocognitive Assessment in TAVI
Lead Sponsor:
Brighton and Sussex University Hospitals NHS Trust
Collaborating Sponsors:
University of Melbourne
Terumo Medical Corporation
Conditions:
Aortic Valve Disease
Eligibility:
All Genders
18+ years
Brief Summary
Severe aortic stenosis is a common heart condition affecting elderly patients. Degeneration of the aortic valve (oneway valve between the heart and the aorta) causes high resistence to blood flow, res...
Eligibility Criteria
Inclusion
- Randomised in the BHF PROTECT-TAVI trial (assessing stroke outcomes in TAVI with and without filter use).
- Willing to provide informed consent for participation in this trial.
Exclusion
- Participant has been excluded from use of the filter device due to anatomical or clinical contra-indications.
- Inadequate English skills.
- Inability to complete assessment tasks due to visual or auditory impairment.
Key Trial Info
Start Date :
May 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 13 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06120946
Start Date
May 18 2021
End Date
December 13 2022
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Sussex County Hospital
Brighton, East Sussex, United Kingdom, BN2 5BE